VirtPrex Prenatal/Postnatal Tablets, Prescription Supplement Containing Folic Acid and DHA, packa...

FDA Recall #D-0241-2017 — Class III — December 12, 2016

Recall #D-0241-2017 Date: December 12, 2016 Classification: Class III Status: Terminated

Product Description

VirtPrex Prenatal/Postnatal Tablets, Prescription Supplement Containing Folic Acid and DHA, packaged in 30-count bottle, Rx only, Made in Canada, NDC 76439-348-30

Reason for Recall

cGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.

Recalling Firm

VIRTUS PHARMACEUTICALS OPCO II L — Nashville, TN

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

124,250 bottles

Distribution

Nationwide

Code Information

Lots #: 21506124 Exp. Date 5/30/2017, 21511151 Exp. date 10/30/2017, 21511151A Exp. Data 10/30/2017, 21512163 Exp. date 11/30/2017, 21512164 Exp. date 11/30/2017

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated